Literature DB >> 8113361

Familial occurrence of telangiectatic osteosarcoma: cousin cases.

J Nishida1, M Abe, H Shiraishi, T Shimamura, G Tamura, T Satoh, S Ehara.   

Abstract

Familial occurrence of osteosarcoma is rare. We report cousin cases, an 11-year-old girl and an 8-year-old boy with telangiectatic osteosarcoma. The tumors occurred in the metaphysis of the distal tibia and the lamina of thoracic vertebra. The local behaviors appeared aggressive, but the clinical courses were relatively indolent in both cases. The histologic features were similar, showing anaplastic tumor cells producing osteoid and proliferation of blood cavities. Clustering of malignancies within a family suggests the presence of a genetic factor.

Entities:  

Mesh:

Year:  1994        PMID: 8113361     DOI: 10.1097/01241398-199401000-00023

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  5 in total

1.  Telangiectatic osteosarcoma of the spine: a case report.

Authors:  R Amritanand; K Venkatesh; R Cherian; A Shah; G D Sundararaj
Journal:  Eur Spine J       Date:  2008-04-18       Impact factor: 3.134

2.  Telangiectatic osteosarcoma: a review of literature.

Authors:  Jun-Jian Liu; Shen Liu; Jian-Guang Wang; Wei Zhu; Ying-Qi Hua; Wei Sun; Zheng-Dong Cai
Journal:  Onco Targets Ther       Date:  2013-05-28       Impact factor: 4.147

3.  The genetics of osteosarcoma.

Authors:  Jeff W Martin; Jeremy A Squire; Maria Zielenska
Journal:  Sarcoma       Date:  2012-05-20

Review 4.  Spinal osteosarcoma.

Authors:  P Katonis; G Datsis; A Karantanas; A Kampouroglou; S Lianoudakis; S Licoudis; E Papoutsopoulou; K Alpantaki
Journal:  Clin Med Insights Oncol       Date:  2013-08-18

5.  A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice.

Authors:  Michael Rosemann; Iria Gonzalez-Vasconcellos; Tanja Domke; Virginija Kuosaite; Ralf Schneider; Markus Kremer; Jack Favor; Michaela Nathrath; Michael J Atkinson
Journal:  Mol Cancer       Date:  2014-08-04       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.